DermTech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	15.66	15.3	14.52	11.84	5.89	3.36
Revenue Growth (YoY)	9.71%	5.36%	22.64%	101.16%	74.94%	37.76%
Cost of Revenue	14.33	15.02	13.87	10.56	5.98	3.3
Gross Profit	1.33	0.28	0.65	1.27	-0.1	0.06
Selling, General & Admin	73.74	83.08	94.76	62.41	29.9	15.17
Research & Development	14.1	15.24	24.05	16.26	5.29	2.5
Operating Expenses	87.84	98.32	118.81	78.67	35.19	17.67
Operating Income	-86.5	-98.04	-118.17	-77.4	-35.29	-17.61
Interest Expense	-0.01	-0.01	-0.01	-0.02	-0	-2.66
Interest & Investment Income	2.57	2.85	1.35	0.17	0.04	-
Other Non Operating Income (Expenses)	0.01	0.01	0.14	-1.09	-1.23	-0.8
EBT Excluding Unusual Items	-83.93	-95.19	-116.68	-78.34	-36.48	-21.06
Merger & Restructuring Charges	-2.1	-2.1	-	-	-	-
Other Unusual Items	-3.6	-3.6	-	-	-	0.93
Pretax Income	-89.63	-100.89	-116.68	-78.34	-36.48	-20.13
Earnings From Continuing Operations	-	-100.89	-116.68	-78.34	-36.48	-20.13
Net Income	-89.63	-100.89	-116.68	-78.34	-36.48	-20.13
Net Income to Common	-89.63	-100.89	-116.68	-78.34	-36.48	-20.13
Shares Outstanding (Basic)	34	33	30	29	17	7
Shares Outstanding (Diluted)	34	33	30	29	17	7
Shares Change (YoY)	11.45%	8.66%	4.00%	70.12%	142.39%	58.81%
EPS (Basic)	-2.66	-3.09	-3.88	-2.71	-2.15	-2.87
EPS (Diluted)	-2.67	-3.09	-3.88	-2.71	-2.15	-2.87
Free Cash Flow	-72.22	-77.88	-98.57	-64.83	-30.52	-18
Free Cash Flow Per Share	-2.14	-2.39	-3.28	-2.24	-1.80	-2.57
Gross Margin	8.51%	1.80%	4.46%	10.76%	-1.63%	1.78%
Operating Margin	-552.23%	-640.94%	-813.92%	-653.81%	-599.64%	-523.33%
Profit Margin	-572.19%	-659.57%	-803.71%	-661.73%	-619.83%	-598.39%
Free Cash Flow Margin	-461.02%	-509.16%	-678.92%	-547.61%	-518.57%	-535.11%
EBITDA	-84.65	-96.22	-116.53	-76.4	-34.8	-17.52
D&A For EBITDA	1.85	1.82	1.63	1	0.49	0.09
EBIT	-86.5	-98.04	-118.17	-77.4	-35.29	-17.61
Revenue as Reported	15.66	15.3	14.52	11.84	5.89	3.36

Updated May 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.